Schedule 13G ownership disclosure

CAN-FITE BIOPHARMA LTD

Security class unavailable · CUSIP: 13471N102

Event date: 2016-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
553,100
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-16-009675
Form type
SC 13G/A
Filer
Can-Fite BioPharma Ltd.
CIK
CIK 1536196
Filed
Feb 19, 2016
Reporting period
Feb 12, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub